Cardiovascular disease and covid-19: A systematic review

IF 2.5 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS IJC Heart and Vasculature Pub Date : 2024-08-02 DOI:10.1016/j.ijcha.2024.101482

B.A. Krishna , M. Metaxaki , N. Sithole , P. Landín , P. Martín , A. Salinas-Botrán

{"title":"Cardiovascular disease and covid-19: A systematic review","authors":"B.A. Krishna , M. Metaxaki , N. Sithole , P. Landín , P. Martín , A. Salinas-Botrán","doi":"10.1016/j.ijcha.2024.101482","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Cardiovascular complications of COVID-19 are numerous and aspects of this phenomenon are not well known. The main objective of this manuscript is a systematic review of the acute and chronic cardiovascular complications secondary to COVID-19.</p></div><div><h3>Methods</h3><p>A systematic review of the literature through Medline via PubMed was conducted (2020–2024).</p></div><div><h3>Results</h3><p>There is a plethora of effects of COVID-19 on the heart in the acute setting. Here we discuss pathophysiology, myocardial infarctions, heart failure, Takotsubo Cardiomyopathy, myocardial injury, myocarditis and arrhythmias that are caused by COVID-19. Additionally, these cardiovascular injuries can linger and may be an underlying cause of some Long COVID symptoms.</p></div><div><h3>Conclusions</h3><p>Cardiovascular complications of COVID-19 are numerous and life-threatening. Long COVID can affect cardiovascular health. Microclotting induced by SARS-CoV-2 infection could be a therapeutic target for some aspects of Long Covid.</p></div>","PeriodicalId":38026,"journal":{"name":"IJC Heart and Vasculature","volume":"54 ","pages":"Article 101482"},"PeriodicalIF":2.5000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2352906724001489/pdfft?md5=0c8069f7a31260735abcdf03ed6769e7&pid=1-s2.0-S2352906724001489-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJC Heart and Vasculature","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352906724001489","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Cardiovascular complications of COVID-19 are numerous and aspects of this phenomenon are not well known. The main objective of this manuscript is a systematic review of the acute and chronic cardiovascular complications secondary to COVID-19.

Methods

A systematic review of the literature through Medline via PubMed was conducted (2020–2024).

Results

There is a plethora of effects of COVID-19 on the heart in the acute setting. Here we discuss pathophysiology, myocardial infarctions, heart failure, Takotsubo Cardiomyopathy, myocardial injury, myocarditis and arrhythmias that are caused by COVID-19. Additionally, these cardiovascular injuries can linger and may be an underlying cause of some Long COVID symptoms.

Conclusions

Cardiovascular complications of COVID-19 are numerous and life-threatening. Long COVID can affect cardiovascular health. Microclotting induced by SARS-CoV-2 infection could be a therapeutic target for some aspects of Long Covid.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

心血管疾病与 covid-19：系统回顾

背景COVID-19引起的心血管并发症很多，但人们对这一现象的各个方面了解不多。本手稿的主要目的是对 COVID-19 继发的急性和慢性心血管并发症进行系统综述。方法通过 Medline 和 PubMed 对文献进行了系统综述（2020-2024 年）。在此，我们将讨论 COVID-19 导致的病理生理学、心肌梗塞、心力衰竭、Takotsubo 心肌病、心肌损伤、心肌炎和心律失常。此外，这些心血管损伤可能会持续存在，并可能成为某些 Long COVID 症状的潜在原因。长COVID可影响心血管健康。SARS-CoV-2感染诱导的微凝血可能是长COVID某些方面的治疗目标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

IJC Heart and Vasculature Medicine-Cardiology and Cardiovascular Medicine

CiteScore

4.90

自引率

10.30%

发文量

216

审稿时长

56 days

期刊介绍： IJC Heart & Vasculature is an online-only, open-access journal dedicated to publishing original articles and reviews (also Editorials and Letters to the Editor) which report on structural and functional cardiovascular pathology, with an emphasis on imaging and disease pathophysiology. Articles must be authentic, educational, clinically relevant, and original in their content and scientific approach. IJC Heart & Vasculature requires the highest standards of scientific integrity in order to promote reliable, reproducible and verifiable research findings. All authors are advised to consult the Principles of Ethical Publishing in the International Journal of Cardiology before submitting a manuscript. Submission of a manuscript to this journal gives the publisher the right to publish that paper if it is accepted. Manuscripts may be edited to improve clarity and expression.